To investigate the effects of carbon-coating of stents on i n fl aınmatory response we seriall y measured plas ma levels of C-reactive protein (CRP), fibrinogen and cytokines (tumor necrosis factor, interle ukins 1 -~, 6 and 8) in patients w ith sing le vessel coronary stenosis with no any inflammatory or infectious d isease who underwent priınary stent insertion.
Seru m in terleuk in 6 (IL-6) levels increased significantly in both CC-MAC and UC-MAC groups and returned to normal after 24 hours. Pla s ına fibrinogen, CRP levels and leukocyte counts also increased in both gro ups (p<0.05 ). There was no difference between the two groups in regard to IL-6, C RP a nd fibrinogen increase. The percent increase in IL-6, fibrinogen o r CRP levels were no t associated wi th the stent length, stent size or the elinical presentation (all p>0.05). In conclusion stent iınpl an ta ti on increases plasma IL-6, fibrinogen and CRP levels. This unfavorab le inflaının atory response seems not to be effected by carbon coating. Li near radiofrequency catheter ablation with in the tricusp id annulus-infe rior caval vein isthmus can cure typical atri al fl utter. Recently developed new mapping methods have properties that can increase the success rate and decrease overall fluoroscopy time, recurrence rate and nıean RF pulse numbers. In this study, we report the results and properties of radiofrequency cathete r ab lation of typical atrial flutter g uided by a new mapping method , electroanatomic mapping (CARTO). A total of 8 patients (6 men, 2 women; 48.4± 11.5 year-old) presenting to our hospital between June-October 200 1 w ith typical atrial flutter refractory to at least 2 a ntiarrh ythm ic drugs underwent to ab lation procedure with elec troanato nıi c mappin g sy stem (CARTO) . The overall fluoroscopy time, inclu ding the placement of diagnostic catheters, mapping, ablation and; total procedural time were 12.8±3.7 and 76±30.4 minutes, respectively. T he mean number of RF pulses was 9 .5±3.7. In a ll patients, s inus rhythm was obtained and total isthmus block was achieved. No procedure-related complications were seen. After the procedure, atrial fibrillation was seen in one patient. During the follow-up, atrial fluıter recurred in one patient 2 months after the ablation procedure. Electroanatomic mapping during the induc ti on of linear lesions for the ablation of atrial flu tte r permitted a high ly significant reduction in ex posure to t1uoroscopy while maintaining hi gh efficacy. The aim of this study was to dete rmine the effect o f a ng ia te nsin conve rting e nzy me inhibitors and calcium channel blackers o n myocardium and lung tiss ue in c hroni c hy poxic conditions . Fo r this purpose, we have examine d the conjugated diene, malond ia lde hyde (MDA), reduced g lu tathione (GSH) a nd total antiox idant (TAA) levels in rats. T wenty Spraque Daw ley rats were inc luded in the study. Group I rats (n=5 ) we re utili zed as sham an ima ls. G roup 2 (n=5) rats were used as control anim als and they were housed in a hypoxic cha mber for 3 weeks. Group 3 (n=5) anima ls received enala pril 0.2 mg/kg v ia gastric gavage for 3 weeks while they were kept in hypox ic cha mber. G ro up 4 an imals received 0.75 mg/kg nifedipine for 2 1 days while the y we re ke pt in hypox ic condition. All anima ls were sacri ficed at the e nd of 2 1 days and the ir heart and lungs were excised fo r bioche mical determination of tissue damage. Results: Myocardial and lung conju gated diene, MDA and TAA levels were significantly diffe re nt in the contro l group than the nifedipine and e nalapril groups (lung conjugated di en, 9 1.8±5.35 nmol/g in group 2 vs 57 .9±5.1 9 nmol/g in group 3 and 68 .7±3.9 nmol/g in group 4, p<O.OO 1; T AA, 4 .5±0.3 nmol/g in group 2 vs 5. 1 ±0.1 nmol/g in group 3 and 5.2±0. I 4 nmol/g in group 4, p<O.OO J). Ttı e re was no sign ificant diffe re nce be tween the e na la pril and nifedipine groups. In conc lus ion chroni c hypoxia im pairs posti sc hemic my ocardia l a ntioxidant reserve and yie lds to lu ng damage. Enala pril and nifed ipine protects the heart and lungs in chronic hypoxemia against further damage. Background: The mechanisms of the diffe rent hemodynamic a nd elinical respanses to dobutamine infu sio n in mitra l s te nos is a re not c learl y established.The aim of thi s study was to evaluate the changing he modynamic parameters in patiens with mi tral stenosis that correlates with dyspnea du ring do bu ta min e in f u s i o n u s in g D o p p l e r echocardiography and to assess determinants of pulmonary artery press uı·e response.
Methods a nd Resu lts: Fi fty-seven consecutive asympto matic or mild ly symptomatic patie nt (51 women, 6 me n; mean age 43±7, range fro m 26 to 52), New York Heart Association (NY HA) class I (n: 9), c lass II (n: 48) w ith m itral stenosis (mean m itral valve area 1.6±0.4 cm 2 ) were evaluated with do butamine stress ec hocardi ography. Dys pnea developed during dobutam ine infusion in 18 patients (G roup B), but the oth er 39 pa tients rema in ed asymptomatic (group A). T here was a significantly greater inerement in mi tra l peak grad ient (14±7 vs 9 ±4 mmHg, p=0.008 ), mean gradient ( 12±6 vs 6±3 mmHg, p<O. OOO 1 ), and pulmonary artery systolic pressure (23±8 vs 16±6 mmHg, p=0.007) du ring dobutam ine infusion in the patients who developed dyspnea than in those who d id not. Furthermore the hemodynam ic response to dobutamine identified a subgroup of patie nts with more serious mitral ste nosis. Based on these elin ical and hemodynamic resul ts, ma nagement was changed in 12 patie nts (2 1%) : 7 underwent perc utaneous m itral balloon commissurotomy, 4 un derwent mitra l va lve replaceme nt, and l rece ived intens ive medical treatme nt. In all patie nts, p ulmonary artery systolic pressure (p<O.OOO 1 ), m ean m itral gradient (p=O.OO ı) a t rest, mitral valve area (p=0.003) and subvalvular mitral score (p=O.OO 1) which is the sign of the mitral valve damage we re sig nificantly correlated wi th pulmonary arte ry pressure response.
Conclusion: In conclusion, ou r results suggest that patie nts w ho have provoke d dyspnea during the dobutamine in fusion ha ve a g reater increase in he modynamic paramete rs than patients who do not. P ulmonary artery pressure response corre la tes with baseline pulmonary artery pressure, mean gradient, mitra l valve area and subvalvular echo score and pulmonary artery pressure response can be predicted by these parameters.
Key wo rds: mitra l ste n os is, sinu s rhy thm, dobutam ine, echocard iography Introduction: It was re porteel that intravasc ular ultrasound (IVUS), find in gs the gold standard in stent deployme nt, were correlated wi th myocardial frac ti o na l flo w rese rve (FFRm y o) in s te nt d e pl oy ın ent. This study was aimed to assess the usefulness of FFRmyo in sten t deployment.
Methods: In 2 ı patie nts ( I 9 maıe, 2 fem aı e; m ean age 57.4±9.7 years) w ith single-vessel disease and pri mary stent ing plan ned , Mag carbon ste nt corres ponding with refe rence ve s se ı diaınc t e r was implanted and inflated to a I-atm highe r pressure than full stent ex pansion was achieved after basa! quantitative coronary analysis (QCA) and FFRmyo measureme nts. FFRmyo and QCA were secured , and in patients in whom target FFRınyo (>0 .94) and QCA ste nosis (:S;IO%), were not achieved inflation pressures were inc reased with steps of 2 atm to achieve target levels. Pati ents were fo llowed up 6 ınonths, and underwent max imal exercise test in g with Bruce protocol.
Results : A lthough target QCA d i a ın e t e r was achieved in 17 patients afte r first inflation, target FFRmyo was attained in 13 patie nts. O ptimu m FFRınyo was achieved in one patients of spite QCA was not. In 8 patients in whom target levels were not ach ieved second inf lation w as pe rformed , and optimum QCA was obtained in 6 of 8, optimum FFRmyo was obtained in 5 of 8. In the remaining 3 patients both targe t QCA and ta rget FFRmyo we re obtained after the th ird infla tion. Mean infl ation press ure was 1 1.90± 1. 84 a tm (8-1 4 atm) fo r the target QCA and 12.48± 1.66 atın (8-1 4 atm) for the targe t FFRmyo. No patient ex penenced recurre nt an g ina, acute m yocardial infa rction, need fo r revascul arisation and death during the six-month follow-up period. In all pa tients, target hart rate was achieved at exercise testin g and no patie nts exhibiti ng positive test results.
We aimed to evaluate proced ural success rates and ıon g-terın fo llow-up results o f patients who underwent ste nt insertion fo r coronary bifurcation lesions whic h are assoc iated with a lower success and hi gher complication rate than most other lesion types. Forty-five patients who underwent ste nt impla ntation for coronary bifurcation ı es i o n s were incl uded in the study. Angiog raph ic fea tu res and q uantitati ve analys is of each lesion, procedural success rates a nd in-hospital and long-term eli nical outcomes were assessed.
Results: Forty-fi ve patients were included, ın ean age 55.3±1 ı .6 years, 75 .5% mal e, 46.4% w ith unstable ang ina , 40% stable a ng ina, and 13 .4% ac ute ın yoca rd ial in farction. The left anterio r descend ing/diagonal bifurca tion was involved in 4 6.9% of cases, circum flex/marginal in 28.9%, PDA/PLA in 19.7%, left anterior descending/circumfl ex in 4.5%. The m ain bra ncl1 (3.06±0. 36 mm refere nce d iameter) and the side brancl1 (2.4±0.39 mm) was stented in all cases. Procedural success was obtained in 84.4% in both branc hes. At 1-month fo ll ow-up, the major card iac event rate (MACE) was 8.8% (death 4.4%, emergency CABG 0 %, non-Q -wave MI 2.2%, repea t PTCA 2.2%). At 15±8.9 month fo llow-u p, the total M ACE rate was 44.5% (death 15.6%, CABG 15.6%, Q -wave M I 6.7 %, re peat PTCA 13.3%).
Conclus ion: W e concl ude tha t the treatme nt of bifurcation lesions with stenting is associated wi th decreased success and increased complicatio n and MACE rates coınpaı·ed with nonbifurcation lesions. One ınonth later, the patient was admitted with elinical findings of congestive heart failure. There was w ide QRS tachycardia at ECG. Tropon in T !eve! was above 2 ng/ml. White blood cell count was J9500/ınm3 and eosinophi l was 1 1920/mm3. After cessation of tachycardia by using lidocaine, there was right bundle branch-block, precordial Q waves and poor R wave progression at ECG on following days. Severe hypokinesia on anterior wall, moderate mitral insufficiency, moderate systolic dysfunction, mild pe ricardi al effus ion and severe pulmonary hypertension were present a t echocard iographic in ves ti gation. Heparin, aspirin, nitrog lyce ri n, furosemide, losartan and digoxine was given to the patient. The investigations about parasitic infections and coJlage n-vasc ular disease were negative. The patie nt was diagnosed as having idiopathic hypereosinophilic syndrome and methylprednisolone w as given at a dose of 40 mg/day, fo llowed by aıne lioration of findings. Coronary arteries were fo und normal but an terolateral hypokinesia and apical akinesia were found. Two months later at control echocardiography, systolic function was better than previous examination a nd systolic pulmonary artery pressure was found to be lower. This represents a rare development of acu te severe myocarditis in a patien t with hype reos inophi lic syndrome, we decided to report this case. A patient presenting with the complaints of sweJling in face and upper body , dyspnea and a shar p chest pain was diagnosed as hav ing vena cava supe ri or syndrome, ple uri sy and pericarditis due to Behçet's disease. Differential diag nosis and follow-up findings were discussed w ith reference to the literature. K ey words: Behçet's disease, thrombosis, pleurisy, pericarditis
Key words: Coronary bifu rcation, ste nt insertion

